Recommended Composition of Flu Vaccines for 2024-2025

The WHO recommends that trivalent vaccines for use in the 2024-2025 northern hemisphere influenza season contain the following: Egg-based vaccines an A/Victoria/4897/2022 (H1N1)pdm09-like virus;  an A/Thailand/8/2022 (H3N2)-like virus; and a B/Austria/1359417/2021 (B/Victoria lineage)-like virus. Cell culture- or recombinant-based vaccines an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; an A/Massachusetts/18/2022 (H3N2)-like virus; and a B/Austria/1359417/2021 (B/Victoria lineage)-like virus. For quadrivalent egg- or cell culture-based or recombinant vaccines for use in the 2024-2025 northern hemisphere influenza season: While the B/Yamagata lineage vaccine component should be excluded as it is no longer warranted, where quadrivalent vaccines are still in use, the B/Yamagata lineage component remains unchanged: Egg-, cell- or Read More …

DPH Confirms Flu-Related Deaths During 2023-2024 Season

NEWS FROM THE DEPARTMENT OF HEALTH AND SOCIAL SERVICES FOR IMMEDIATE RELEASE For more information, contact Laura Matusheski, Media Relations Coordinator, (302) 824-3970 or DPHMedia@delaware.gov. DPH Confirms Flu-Related Deaths During 2023-2024 Flu Season, Urges Public to Get Vaccinated DOVER, DE (Jan. 30, 2024) – The Delaware Division of Public Health (DPH) announced today six (6) suspected flu-related deaths for the 2023-2024 influenza season. The first recorded death of the season was in December. All decedents were over the age of 55 with one reportedly up to date on their flu vaccination. Three of the decedents were New Castle County residents, Read More …